Galectin Therapeutics Inc. (GALT) vs Turn Therapeutics Inc. (TTRX)
Galectin Therapeutics Inc. and Turn Therapeutics Inc. are both Biotechnology companies. Galectin Therapeutics Inc. and Turn Therapeutics Inc. are of similar size ($399.4M and $395.0M). Across the 8 metrics below, Galectin Therapeutics Inc. leads on 4 and Turn Therapeutics Inc. on 4.
Valuation
Profitability
| Metric | GALT | TTRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 21.69% | (3,315.33%) | (57.72%) |
| Return on assets | (184.22%) | (99.59%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack